Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-648-4088
Fax+1 214-648-4067
Dr. Zheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Wenxin Zheng is a pathologist based in Dallas, TX, with subspecialties in Gynecologic Pathology and Anatomic Pathology. His extensive education includes a residency in Pathology at New York Presbyterian Hospital and further specialization in Gynecologic Pathology at Women and Infants Hospital of Rhode Island/Brown University. Dr. Zheng's research and publications, which cover topics in all women's major cancers such as neoplasms of the ovary, endometrium, and cervix. He has made significant original contributions in the field of gynecologic pathology and gynecologic oncology. He is recognized as one of the few leading gynecologic pathologists worldwide. He receives consultations locally, nationally, as well as internationally.
Education & Training
Women and Infants Hospital of Rhode Island/Brown UniversityResidency, Gynecologic Pathology, 1995 - 1996
New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 1992 - 1995- New York-Presbyterian HospitalPost-Doctoral Fellowship, 1986 - 1991
Shanghai Medical UniversityClass of 1982
Certifications & Licensure
CA State Medical License 1996 - Present
TX State Medical License 2016 - 2026
FL State Medical License 2018 - 2020
AZ State Medical License 2005 - 2017
CT State Medical License 2000 - 2006
American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- Top Pathologist US and World News Reports, 2013
- Top Doctors:Arizona State Castle Connolly, 2013
Publications & Presentations
PubMed
- Residual disease volume and prognosis in endometrioid precancer after progestin therapy.Fei Liang, Rujia Fan, Ling Chen, Yue Wang, Zhigang Yao
Virchows Archiv. 2025-04-24 - Pilomatrix-like High-grade Endometrial Carcinoma: An Underdiagnosed Entity With Aggressive Clinicopathologic Features.Feng Zhou, Lei Qin, Suming Huang, Wanrun Lin, Huijuan Zhang
The American Journal of Surgical Pathology. 2025-04-09 - Mirvetuximab soravtansine: current and future applications.Beihua Kong, Wenxin Zheng
Journal of Hematology & Oncology. 2025-03-18
Journal Articles
- Metformin Sensitizes Endometrial Cancer Cells to Chemotherapy Through IDH1-Induced Nrf2 Expression via an Epigenetic MechanismWenxin Zheng, MD, Nature
- Superficially Invasive Cervical Squamous Cell Carcinoma Metastatic to Ovarian Endometriotic Cyst Wall, a Case Report and Brief Review of the LiteratureElena Lucas, Wenxin Zheng, Kyle Molberg, BioMed Central
- Combination of TP53 and AGR3 to Distinguish Ovarian High-Grade Serous Carcinoma from Low-Grade Serous CarcinomaWenxin Zheng, MD, Spandidos Publications
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
